Associations between peripheral whole blood cell counts derived indexes and cancer prognosis: An umbrella review of meta-analyses of cohort studies
- Ying-Ying Zhang 1, Fang-Hua Liu 1, Ya-Li Wang 2, Jia-Xin Liu 1, Lang Wu 3, Ying Qin 1, Wen-Rui Zheng 1, Wei-Yi Xing 1, Jin Xu 4, Xing Chen 1, He-Li Xu 1, Qi Bao 4, Jia-Yi Wang 4, Ran Wang 1, Xi-Yang Chen 1, Yi-Fan Wei 1, Bing-Jie Zou 1, Jia-Cheng Liu 4, Jia-Li Yin 1, Ming-Qian Jia 1, Song Gao 4, Meng Luan 4, Hui-Han Wang 5, Ting-Ting Gong 4, Qi-Jun Wu 6
- Ying-Ying Zhang 1, Fang-Hua Liu 1, Ya-Li Wang 2
- 1Department of Clinical Epidemiology, Shengjing Hospital of China Medical University, Shenyang, China; Clinical Research Center, Shengjing Hospital of China Medical University, Shenyang, China; Key Laboratory of Precision Medical Research on Major Chronic Disease, Shengjing Hospital of China Medical University, Shenyang, China.
- 2Department of Clinical Epidemiology, Shengjing Hospital of China Medical University, Shenyang, China; Department of Information Center, The Fourth Affiliated Hospital of China Medical University, Shenyang, China.
- 3Cancer Epidemiology Division, Population Sciences in the Pacific Program, University of Hawaii Cancer Center, University of Hawaii at Manoa, Honolulu, HI, USA.
- 4Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, China.
- 5Department of Hematology, Shengjing Hospital of China Medical University, Shenyang, China.
- 6Department of Clinical Epidemiology, Shengjing Hospital of China Medical University, Shenyang, China; Clinical Research Center, Shengjing Hospital of China Medical University, Shenyang, China; Key Laboratory of Precision Medical Research on Major Chronic Disease, Shengjing Hospital of China Medical University, Shenyang, China; Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, China; NHC Key Laboratory of Advanced Reproductive Medicine and Fertility (China Medical University), National Health Commission, Shenyang, China.
- 0Department of Clinical Epidemiology, Shengjing Hospital of China Medical University, Shenyang, China; Clinical Research Center, Shengjing Hospital of China Medical University, Shenyang, China; Key Laboratory of Precision Medical Research on Major Chronic Disease, Shengjing Hospital of China Medical University, Shenyang, China.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This umbrella review assessed whole blood cell count indexes and cancer prognosis. While some associations show suggestive evidence, inconsistent effect sizes necessitate further research for definitive conclusions.
Area Of Science
- Oncology
- Hematology
- Biostatistics
Background
- Conflicting meta-analyses exist on whole blood cell count (WBCC) derived indexes and cancer prognosis.
- Indexes include neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and lymphocyte-to-monocyte ratio (LMR).
- The aggregate strength and quality of evidence require quantification.
Purpose Of The Study
- To grade the evidence from published meta-analyses of cohort studies.
- Investigate associations between NLR, PLR, LMR, and cancer prognosis.
- Summarize existing evidence on WBCC-derived indexes and cancer outcomes.
Main Methods
- Umbrella review methodology.
- Inclusion of 694 associations from 224 articles.
- Quality assessment using AMSTAR, with 97.8% rated moderate-to-high.
Main Results
- Four associations demonstrated convincing evidence.
- 165 associations had highly suggestive evidence.
- 164 associations showed suggestive evidence.
Conclusions
- Existing evidence on WBCC-derived indexes and cancer prognosis is summarized.
- Inconsistent effect size directions across studies indicate a need for further research.
- Causality and firm evidence require additional investigation.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
01:21
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
01:15
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...

